ヘリオスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/12/06 | 1,530 | 1,574 | 1,480 | 1,530 | +38 | +2.5% | 633,600 |
| 2017/12/05 | 1,502 | 1,508 | 1,450 | 1,492 | -16 | -1.1% | 104,300 |
| 2017/12/04 | 1,507 | 1,510 | 1,476 | 1,508 | +22 | +1.5% | 124,400 |
| 2017/12/01 | 1,505 | 1,506 | 1,486 | 1,486 | -15 | -1% | 60,300 |
| 2017/11/30 | 1,481 | 1,513 | 1,472 | 1,501 | +19 | +1.3% | 147,300 |
| 2017/11/29 | 1,496 | 1,505 | 1,476 | 1,482 | -14 | -0.9% | 89,400 |
| 2017/11/28 | 1,486 | 1,504 | 1,478 | 1,496 | +6 | +0.4% | 130,900 |
| 2017/11/27 | 1,497 | 1,518 | 1,486 | 1,490 | +1 | +0.1% | 122,900 |
| 2017/11/24 | 1,490 | 1,510 | 1,485 | 1,489 | -11 | -0.7% | 126,000 |
| 2017/11/22 | 1,499 | 1,503 | 1,479 | 1,500 | ±0 | ±0% | 79,600 |
| 2017/11/21 | 1,502 | 1,510 | 1,489 | 1,500 | -2 | -0.1% | 125,000 |
| 2017/11/20 | 1,454 | 1,502 | 1,453 | 1,502 | +60 | +4.2% | 177,300 |
| 2017/11/17 | 1,420 | 1,446 | 1,420 | 1,442 | +13 | +0.9% | 76,100 |
| 2017/11/16 | 1,425 | 1,438 | 1,408 | 1,429 | +27 | +1.9% | 101,400 |
| 2017/11/15 | 1,399 | 1,425 | 1,390 | 1,402 | -3 | -0.2% | 78,000 |
| 2017/11/14 | 1,413 | 1,426 | 1,393 | 1,405 | -11 | -0.8% | 68,400 |
| 2017/11/13 | 1,390 | 1,428 | 1,377 | 1,416 | +38 | +2.8% | 86,600 |
| 2017/11/10 | 1,381 | 1,399 | 1,363 | 1,378 | -9 | -0.6% | 132,100 |
| 2017/11/09 | 1,444 | 1,450 | 1,381 | 1,387 | -62 | -4.3% | 194,900 |
| 2017/11/08 | 1,467 | 1,467 | 1,448 | 1,449 | -3 | -0.2% | 58,600 |
| 2017/11/07 | 1,453 | 1,460 | 1,442 | 1,452 | +3 | +0.2% | 56,800 |
| 2017/11/06 | 1,466 | 1,473 | 1,449 | 1,449 | -9 | -0.6% | 47,900 |
| 2017/11/02 | 1,489 | 1,489 | 1,456 | 1,458 | -2 | -0.1% | 69,200 |
| 2017/11/01 | 1,470 | 1,490 | 1,448 | 1,460 | -14 | -0.9% | 113,300 |
| 2017/10/31 | 1,503 | 1,503 | 1,473 | 1,474 | -26 | -1.7% | 53,400 |
| 2017/10/30 | 1,481 | 1,509 | 1,480 | 1,500 | +20 | +1.4% | 83,400 |
| 2017/10/27 | 1,471 | 1,488 | 1,470 | 1,480 | +6 | +0.4% | 53,600 |
| 2017/10/26 | 1,487 | 1,487 | 1,460 | 1,474 | +8 | +0.5% | 47,500 |
| 2017/10/25 | 1,488 | 1,488 | 1,455 | 1,466 | -4 | -0.3% | 42,000 |
| 2017/10/24 | 1,475 | 1,480 | 1,461 | 1,470 | -4 | -0.3% | 43,600 |
| 2017/10/23 | 1,494 | 1,494 | 1,473 | 1,474 | -17 | -1.1% | 57,400 |
| 2017/10/20 | 1,491 | 1,491 | 1,466 | 1,491 | +26 | +1.8% | 68,300 |
| 2017/10/19 | 1,495 | 1,499 | 1,465 | 1,465 | -43 | -2.9% | 158,600 |
| 2017/10/18 | 1,520 | 1,521 | 1,462 | 1,508 | -13 | -0.9% | 151,000 |
| 2017/10/17 | 1,517 | 1,525 | 1,505 | 1,521 | +16 | +1.1% | 178,700 |
| 2017/10/16 | 1,502 | 1,517 | 1,501 | 1,505 | -8 | -0.5% | 83,500 |
| 2017/10/13 | 1,490 | 1,513 | 1,477 | 1,513 | +38 | +2.6% | 144,500 |
| 2017/10/12 | 1,491 | 1,531 | 1,460 | 1,475 | +2 | +0.1% | 164,400 |
| 2017/10/11 | 1,470 | 1,510 | 1,453 | 1,473 | +26 | +1.8% | 75,200 |
| 2017/10/10 | 1,485 | 1,489 | 1,447 | 1,447 | -33 | -2.2% | 45,900 |
| 2017/10/06 | 1,440 | 1,500 | 1,440 | 1,480 | +41 | +2.8% | 75,300 |
| 2017/10/05 | 1,470 | 1,470 | 1,438 | 1,439 | -29 | -2% | 64,700 |
| 2017/10/04 | 1,510 | 1,518 | 1,462 | 1,468 | -42 | -2.8% | 89,900 |
| 2017/10/03 | 1,488 | 1,510 | 1,478 | 1,510 | -2 | -0.1% | 134,100 |
| 2017/10/02 | 1,418 | 1,512 | 1,414 | 1,512 | +98 | +6.9% | 274,900 |
| 2017/09/29 | 1,385 | 1,419 | 1,375 | 1,414 | +25 | +1.8% | 126,900 |
| 2017/09/28 | 1,373 | 1,390 | 1,370 | 1,389 | +7 | +0.5% | 65,600 |
| 2017/09/27 | 1,383 | 1,398 | 1,371 | 1,382 | -5 | -0.4% | 53,000 |
| 2017/09/26 | 1,374 | 1,409 | 1,374 | 1,387 | -2 | -0.1% | 38,500 |
| 2017/09/25 | 1,373 | 1,399 | 1,370 | 1,389 | +23 | +1.7% | 35,700 |
1701～
1750
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| Ｃｈｏｒｄｉａ | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
